Synthesis of 3"-substituted TSAO derivatives with anti-HIV-1 and anti-HIV-2 activity through an efficient palladium-catalyzed cross-coupling approach

被引:23
作者
Lobatón, E
Rodríguez-Barrios, F
Gago, F
Pérez-Pérez, MJ
De Clercq, E
Balzarini, J
Camarasa, MJ
Velázquez, S
机构
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
[2] Univ Alcala de Henares, Dept Farmacol, E-28871 Alcala De Henares, Spain
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1021/jm020820h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Various synthetic studies for the introduction of several functional groups at position 3" of the spiro moiety of TSAO derivatives have been explored. Among, them, Stille cross-coupling of 3"-iodo-TSAO derivatives with different stannanes provided an efficient and straightforward route for the direct and selective functionalization of the 3"-position of the sultone spiro moiety via carbon-carbon bond formation. The compounds synthesized were evaluated for their inhibitory effect on HIV-1 and HIV-2 replication in cell culture. The introduction of a bromine and particularly an iodine at the 3"-position conferred the highest anti-HIV-1 activity. In contrast, the presence at this position of (un)substituted vinyl, alkynyl, phenyl, or thienyl groups markedly diminished the anti-HIV-1 activity. Surprisingly, several of the 3"-alkenyl-substituted TSAO derivatives also gained anti-HIV-2 activity at subtoxic concentrations, an observation that is very unusual for NNRTIs and never observed before for TSAO derivatives. Finally, the anti-HIV-1 activity of some of the 3"-substituted TSAO derivatives is discussed in light of our recently proposed molecular model of interaction of TSAO derivatives with the interphase between the two subunits of HIV-1 reverse transcriptase.
引用
收藏
页码:3934 / 3945
页数:12
相关论文
共 46 条
[1]   Synthesis and anti-human immunodeficiency virus type 1 activity of novel 3'-spiro nucleoside analogues of TSAO-T [J].
Alvarez, R ;
Jimeno, ML ;
PerezPerez, MJ ;
DeClercq, E ;
Balzarini, J ;
Camarasa, MJ .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06) :507-517
[2]  
Alvarez R, 1998, ANTIVIR CHEM CHEMOTH, V9, P333
[3]   CERIUM(IV)-MEDIATED HALOGENATION AT C-5 OF URACIL DERIVATIVES [J].
ASAKURA, J ;
ROBINS, MJ .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (16) :4928-4933
[4]   CERIUM(IV) CATALYZED IODINATION AT C5 OF URACIL NUCLEOSIDES [J].
ASAKURA, J ;
ROBINS, MJ .
TETRAHEDRON LETTERS, 1988, 29 (23) :2855-2858
[5]   [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE) (TSAO) DERIVATIVES OF PURINE AND PYRIMIDINE NUCLEOSIDES AS POTENT AND SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BALZARINI, J ;
PEREZPEREZ, MJ ;
SANFELIX, A ;
VELAZQUEZ, S ;
CAMARASA, MJ ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1073-1080
[6]   2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1',2''-OXATHIOLE-2'',2''-DIOXIDE)PYRIMIDINE (TSAO) NUCLEOSIDE ANALOGS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE [J].
BALZARINI, J ;
PEREZPEREZ, MJ ;
SANFELIX, A ;
SCHOLS, D ;
PERNO, CF ;
VANDAMME, AM ;
CAMARASA, MJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4392-4396
[7]  
BALZARINI J, 1992, J BIOL CHEM, V267, P11831
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS SELECTED FOR RESISTANCE AGAINST THE HIV-1-SPECIFIC [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE)]-BETA-D-PENTOFURANOSYL (TSAO) NUCLEOSIDE ANALOGS RETAIN SENSITIVITY TO HIV-1-SPECIFIC NONNUCLEOSIDE INHIBITORS [J].
BALZARINI, J ;
KARLSSON, A ;
VANDAMME, AM ;
PEREZPEREZ, MJ ;
ZHANG, H ;
VRANG, L ;
OBERG, B ;
BACKBRO, K ;
UNGE, T ;
SANFELIX, A ;
VELAZQUEZ, S ;
CAMARASA, MJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :6952-6956
[9]   SENSITIVITY OF (138 GLU-]LYS) MUTATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE (RT) TO HIV-1-SPECIFIC RT-INHIBITORS [J].
BALZARINI, J ;
KLEIM, JP ;
RIESS, G ;
CAMARASA, MJ ;
DECLERCQ, E ;
KARLSSON, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) :1305-1312
[10]   A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL [J].
BAYLY, CI ;
CIEPLAK, P ;
CORNELL, WD ;
KOLLMAN, PA .
JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) :10269-10280